... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Neuroendocrine tumour Peptide receptor radionuclide therapy Molecular therapy Neuroendocrine tumours (NETs) are relatively rare tumours that are usually slow...

..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2023 Neuroendocrine tumour Neuroendocrine neoplasm Metachronous tumour...

.... 2022 Carcinoid crises Hormonal crises Lutate Peptide receptor radionuclide therapy Neuroendocrine tumour The purpose of this consensus document is to assist clinicians by providing practical advice on the identification of patients at risk, prevention and treatment of hormonal crises...

..., and anatomical location, and this is reflected by diverse biological behaviour and subsequent prognosis. Neuroendocrine tumour Carcinoid Endoscopy Surveillance © 2020 S. Karger AG, Basel 2020 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may...

..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Diagnosis Neuroendocrine tumour Neuroendocrine neoplasm Imaging...

.... Neuroendocrine tumour Neuroendocrine neoplasm Small intestine Pancreas Neuroendocrine neoplasms (NEN) comprise a heterogeneous collection of tumours derived from widely distributed neuroendocrine cells, most commonly arising from the gastroenteropancreatic (GEP) and bronchopulmonary tracts [ 1, 2...

.... Carcinoid tumours Gastroenteropancreatic neuroendocrine tumours Neuroendocrine tumour Somatostatin receptor 1 07 2018 14 09 2018 16 9 2018 [email protected] Conference Report Neuroendocrinology 2019;108:45 53 DOI: 10.1159/000493767 Received: July 1, 2018 Accepted after...

..., instructions or products referred to in the content or advertisements. Small bowel Neuroendocrine tumour Mesenteric fibrosis Survival Small intestinal neuroendocrine tumours (SI NETs) represent 30–50% of small bowel neoplasms with an annual incidence of 1.05 per 100,000 persons according...

... Hospital Neuroendocrine Tumour Service and from subject matter experts at the NPF. The finalized survey contained 130 questions and was estimated to take 30 min to complete online. Subsets of questions included first and worst symptoms, weight and appetite change, pain and discomfort, nausea and vomiting...

..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Follow-up Neuroendocrine tumour Surveillance Survey Neuroendocrine...

... to in the content or advertisements. Endoscopic ultrasound-guided fine needle aspiration Ki67 Pancreas Neuroendocrine tumour Grading Pancreatic neuroendocrine tumours (pNETs) are nowadays easily recognized and diagnosed by endoscopic ultrasound-guided fine needle aspiration (EUS-FNA...

... reported by patients in some way, but since most papers are retrospective analyses, the mode of patient reporting is not standardised. Table 4 Five most frequently reported symptoms by pancreatic neuroendocrine tumour subtype Of interest is that in gastrinoma the most prominent symptom...

..., instructions or products referred to in the content or advertisements. Radiolabelled somatostatin analogues Gastroenteropancreatic neuroendocrine tumour Neuroendocrine tumour Peptide receptor radionuclide therapy Based on the frequent expression of somatostatin receptors (SSTR...

... to the LC [ 22,23,24,25 ]. Gallium DOTANOC Positron emission tomography Lung carcinoid Lung Neuroendocrine tumour Table 3 Summary of patients' treatment; information was not available for one of the patients (information for 45 patients is provided) Most patients were diagnosed...

... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2017 Everolimus Sunitinib Pancreas Molecular agents Survival Neuroendocrine tumour...

.... Thymus Carcinoid Neuroendocrine tumour Ectopic ACTH Multiple endocrine neoplasia-1 Bronchopulmonary carcinoids Thymic neuroendocrine neoplasms (NEN) are rare tumours. In the most recent SEER database, the incidence of thymic NENs was 0.02/100,000 population per year [ 1 ] among Caucasian...

... therapeutic options are recommended or approved for pancreatic neuroendocrine tumour (pNET). The primary endpoint of this study was to determine the number of therapeutic lines given before death. Secondary endpoints were to determine toxic events as a function of number of therapeutic lines and of time...

... suggests that environmental factors may also be important in the development of NETs. Neuroendocrine tumour Epidemiology Incidence Neuroendocrine carcinoma Carcinoid Neuroendocrine tumours (NETs) comprise a heterogeneous group of neoplasias originating in a broad diversity of tissues...

... in clinical trials. The aim of this study was to investigate the effects of valproic acid (VPA), an inhibitor of class I and class IIa HDACs, on neuroendocrine tumour (NET) cell growth. Methods: Three NET cell lines, GOT1 (small intestinal), KRJ-I (small intestinal), and BON (pancreatic), were treated...

[email protected] Neuroendocrine tumour Second primary cancer Neuroendocrine tumour disease - most recently reclassified as neuroendocrine neoplasms [ 1 ] - represents a spectrum of individually uncommon malignancies originating from the body's neuroendocrine cell system, with most neuroendocrine...